Stay updated on Daratumumab for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded the topic 'Multiple myeloma' to the page and introduced a new external resource link to the Genetic and Rare Diseases Information Center under resources.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site revision in the footer was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check37 days agoChange DetectedResults have been posted for this study, including MRD negativity rates after ASCT and after consolidation/maintenance, progression-free and overall survival, overall response rate, adverse events, and MRD testing methods, with corresponding data submission dates.SummaryDifference2%

- Check59 days agoChange DetectedResults Submitted is now displayed on the study page, replacing the previous 'No Results Posted' status.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.